Image For Activity Cover
Adherence to Onabotulinumtoxina Treatment in Post-Stroke and Multiple Sclerosis Patients with Spasticity from the ASPIRE Study
Adherence to Onabotulinumtoxina Treatment in Post-Stroke and Multiple Sclerosis Patients with Spasticity from the ASPIRE Study
From the AAPM&R Annual Assembly 2020, Alberto Esquinazi, MD, gives a poster talk on the abstract "Adherence to Onabotulinumtoxina Treatment in Post-Stroke and Multiple Sclerosis Patients with Spasticity from the ASPIRE Study."



Summary
Availability: On-Demand
Expires on Apr 30, 2025
Cost: Member: $10.00
Non-Member: $25.00
Resident Member: $10.00
Resident Non-Member: $25.00
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By